| Primary |
| Diabetes Mellitus |
45.7% |
| Type 2 Diabetes Mellitus |
13.5% |
| Hypertension |
7.0% |
| Blood Glucose Increased |
6.0% |
| Depression |
3.9% |
| Blood Cholesterol Increased |
3.4% |
| Arthritis |
3.1% |
| Back Pain |
2.1% |
| Glaucoma |
2.1% |
| Ill-defined Disorder |
2.1% |
| Blood Glucose Abnormal |
1.6% |
| Pain |
1.6% |
| Blood Pressure Abnormal |
1.3% |
| Arrhythmia |
1.0% |
| Muscle Injury |
1.0% |
| Sciatica |
1.0% |
| Tachyarrhythmia |
1.0% |
| Vein Disorder |
1.0% |
| Atrial Fibrillation |
0.8% |
| Bladder Disorder |
0.8% |
|
| Blood Glucose Increased |
13.0% |
| Malaise |
11.2% |
| Drug Ineffective |
9.9% |
| Death |
8.1% |
| Visual Impairment |
6.2% |
| Visual Acuity Reduced |
5.6% |
| Cardiac Disorder |
5.0% |
| Memory Impairment |
5.0% |
| Hypoglycaemia |
4.3% |
| Weight Increased |
4.3% |
| Hypertension |
3.7% |
| Medication Residue |
3.7% |
| Nausea |
3.1% |
| Tremor |
3.1% |
| Weight Decreased |
3.1% |
| Blood Glucose Decreased |
2.5% |
| Muscle Spasms |
2.5% |
| Cardiac Failure Congestive |
1.9% |
| Diabetes Mellitus |
1.9% |
| Diabetes Mellitus Inadequate Control |
1.9% |
|
| Secondary |
| Diabetes Mellitus |
36.0% |
| Depression |
14.7% |
| Hypertension |
7.3% |
| Type 2 Diabetes Mellitus |
6.5% |
| Tachyarrhythmia |
6.1% |
| Blood Cholesterol Increased |
4.2% |
| Pain |
3.2% |
| Drug Use For Unknown Indication |
2.3% |
| Dyslipidaemia |
2.3% |
| High Density Lipoprotein Decreased |
2.1% |
| Product Used For Unknown Indication |
2.0% |
| Ill-defined Disorder |
1.8% |
| Back Pain |
1.7% |
| Neuropathy Peripheral |
1.7% |
| Anxiety |
1.5% |
| Arthritis |
1.5% |
| Diabetes Mellitus Non-insulin-dependent |
1.5% |
| Cardiac Disorder |
1.4% |
| Blood Glucose Increased |
1.2% |
| Wheezing |
1.2% |
|
| Myocardial Infarction |
16.8% |
| Malaise |
8.9% |
| Diabetes Mellitus |
7.9% |
| Death |
6.9% |
| Drug Ineffective |
6.9% |
| Weight Decreased |
6.9% |
| Blood Glucose Increased |
5.9% |
| Rash |
4.0% |
| Deafness |
3.0% |
| Headache |
3.0% |
| Hearing Impaired |
3.0% |
| Hypoglycaemia |
3.0% |
| Nausea |
3.0% |
| Neoplasm Malignant |
3.0% |
| Pain |
3.0% |
| Pneumonia |
3.0% |
| Pyrexia |
3.0% |
| Renal Failure |
3.0% |
| Respiratory Arrest |
3.0% |
| Skin Disorder |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.2% |
| Diabetes Mellitus |
15.3% |
| Type 2 Diabetes Mellitus |
10.9% |
| Drug Use For Unknown Indication |
10.6% |
| Diabetes Mellitus Non-insulin-dependent |
9.0% |
| Hypertension |
6.8% |
| Depression |
5.4% |
| Anxiety |
3.9% |
| Blood Cholesterol Increased |
2.6% |
| Pain |
2.5% |
| Bipolar Disorder |
2.1% |
| Coronary Artery Bypass |
2.1% |
| Arthritis |
2.0% |
| Cardiac Disorder |
1.8% |
| Multiple Myeloma |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Insomnia |
1.5% |
| Back Pain |
1.4% |
| Sleep Disorder |
1.3% |
| Intervertebral Disc Degeneration |
1.3% |
|
| Weight Decreased |
22.5% |
| Myocardial Infarction |
16.2% |
| Weight Increased |
9.3% |
| Vomiting |
6.6% |
| Type 2 Diabetes Mellitus |
6.3% |
| Nausea |
4.9% |
| Pain |
4.6% |
| Blood Glucose Increased |
4.3% |
| Transient Ischaemic Attack |
3.4% |
| Cerebrovascular Accident |
2.9% |
| Drug Ineffective |
2.9% |
| Cardiac Failure Congestive |
2.6% |
| Coronary Artery Disease |
2.0% |
| Renal Failure |
2.0% |
| Urinary Tract Infection |
2.0% |
| Injury |
1.7% |
| Myocardial Ischaemia |
1.6% |
| Vision Blurred |
1.6% |
| Pancreatitis |
1.3% |
| Respiratory Failure |
1.3% |
|
| Interacting |
| Diabetes Mellitus |
31.2% |
| Depression |
16.5% |
| Hypertension |
11.8% |
| Tachyarrhythmia |
8.2% |
| Blood Cholesterol Increased |
5.9% |
| Dyslipidaemia |
4.1% |
| High Density Lipoprotein Decreased |
4.1% |
| Bladder Spasm |
2.9% |
| Fungal Infection |
2.9% |
| Pain |
2.9% |
| Pollakiuria |
2.9% |
| Urinary Tract Infection |
2.9% |
| Drug Use For Unknown Indication |
1.8% |
| Hypercholesterolaemia |
1.2% |
| Palpitations |
0.6% |
|
| Myocardial Infarction |
33.3% |
| Nasopharyngitis |
33.3% |
| Retinal Oedema |
14.3% |
| Blood Glucose Decreased |
9.5% |
| Drug Ineffective |
4.8% |
| Drug Interaction |
4.8% |
|
